Tag: macular degeneration treatment market share analysis

  • Macular Degeneration Treatment Market Forecast 2024-2033: Anticipated Size and Growth Trends

    Macular Degeneration Treatment Market Forecast 2024-2033: Anticipated Size and Growth Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    2024-2033 Macular Degeneration Treatment Market: What Growth Rate is Predicted?

    Rapid expansion has been witnessed in the market size of macular degeneration treatment in the recent past. Projected to increase from $9.74 billion in 2023 to $10.99 billion in 2024, the Compound Annual Growth Rate (CAGR) is expected to be 12.8%. A variety of factors have contributed to this growth during the historic period, including an aging population, changes in lifestyle, the limited availability of treatment options, growing awareness, and advancements in healthcare infrastructure.

    The market for macular degeneration treatment is predicted to experience substantial growth in the coming years, anticipated to reach $16.99 billion by 2028 with a compound annual growth rate (CAGR) of 11.5%. Various factors such as advancements in research, higher healthcare spending, increasing incidence rates, customized medicinal practices, and worldwide efforts to promote vision health are expected to stimulate this growth during the period in forecast. Key trends projected for this period include emphasis on neuroprotection and regenerative therapies, expansion of telemedicine and remote patient monitoring, personalized treatment strategies, exploration of stem cell therapies, and a patient-centric approach for enhancing awareness and education.

    Claim Your Free Sample of the Global Macular Degeneration Treatment Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp

    What Aspects Are Driving the Expansion of the macular degeneration treatment Market?

    The anticipated upsurge in retinal disorder diagnoses is expected to drive the expansion of the macular degeneration treatment market. These disorders can damage essential tissue, affecting how visual details are processed and resulting in distorted or non-existent vision. The American Academy of Ophthalmology expects that primary open-angle glaucoma, a broad term for various eye diseases, will impact roughly 7.32 million people in the United States by 2050. The parts of the population most at risk include those aged 70 to 79 (32%), women (50%), and Hispanics (50%), with Hispanic males forming the largest demographic group. Consequently, the increasing rate of retinal disorders is promoting the growth of the macular degeneration treatment market.

    What Are the Significant Segments of the Macular Degeneration Treatment Market?

    1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD

    2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals

    3) By Route of Administration: Oral, Injectable, Other Route of Administration

    4) By Types: Wet Macular Degeneration, Dry Macular Degeneration

    What Trends Are Influencing the Evolution of the Macular Degeneration Treatment Market?

    Order Now for Fast Delivery of Your Macular Degeneration Treatment Market Report!

    https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report

    Which Geographic Areas Are Influencing the Growth of the Macular Degeneration Treatment Market?

    North America was the largest region in the macular degeneration treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment market market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Macular Degeneration Treatment Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the macular degeneration treatment market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Macular Degeneration Treatment Market Include

    1. Macular Degeneration Treatment Market Executive Summary

    2. Macular Degeneration Treatment Market Segments

    3. Macular Degeneration Treatment Market Size And Template Market Growth Rate

    4. Key Macular Degeneration Treatment Market Trends

    5. Major Macular Degeneration Treatment Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Macular Degeneration Treatment Market

    26. Top Macular Degeneration Treatment Companies

    27. Macular Degeneration Treatment Market Opportunities And Strategies

    28. Macular Degeneration Treatment Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Hemodialysis And Peritoneal Dialysis Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/hemodialysis-and-peritoneal-dialysis-global-market-report

    Endoscopy Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/endoscopy-devices-and-equipment-global-market-report

    Dialysis Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dialysis-devices-and-equipment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis On Size, Share, And Drivers Of The Macular Degeneration Treatment Market

    Comprehensive Analysis On Size, Share, And Drivers Of The Macular Degeneration Treatment Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    The macular degeneration treatment market has seen remarkable growth in recent years and is poised for continued expansion. This article delves into the factors driving this growth, current trends, and future projections.

    Rapid Market Growth

    • Market Size and Growth Rate:
      • The market grew from $9.74 billion in 2023 to $10.99 billion in 2024.
      • This growth represents a compound annual growth rate (CAGR) of 12.8%.
    • Contributing Factors:
      • Aging Population: Increasing elderly population susceptible to macular degeneration.
      • Lifestyle Changes: Rising cases due to lifestyle factors like smoking and poor diet.
      • Limited Treatment Options: Demand for new and effective treatments.
      • Rising Awareness: Greater awareness leading to early diagnosis and treatment.
      • Healthcare Infrastructure Development: Enhanced healthcare facilities supporting treatment accessibility.

    View More On The Macular Degeneration Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report

    Future Market Projections

    • Expected Market Size:
      • Projected to reach $16.99 billion by 2028.
      • Forecast CAGR of 11.5%.
    • Growth Drivers:
      • Advancements in Research: New treatments and technologies being developed.
      • Increased Healthcare Expenditure: Higher spending on healthcare globally.
      • Rising Incidence Rates: Growing number of macular degeneration cases.
      • Personalized Medicine Approaches: Tailored treatments improving efficacy.
      • Global Vision Health Initiatives: Worldwide efforts to combat vision loss.

    Major Trends in the Forecast Period

    • Focus on Neuroprotection and Regeneration Therapies: Developing treatments that protect and regenerate retinal cells.
    • Expansion of Telemedicine and Remote Monitoring: Leveraging technology for better patient management.
    • Personalized Medicine Approaches: Customized treatments based on genetic and lifestyle factors.
    • Investigation of Stem Cell Therapies: Researching stem cell applications for vision restoration.
    • Patient-Focused Initiatives for Awareness and Education: Educating patients on disease management and prevention.

    Growing Retinal Disorder Incidence Propels Market Growth

    • Increasing Burden of Retinal Disorders:
      • Retinal disorders leading to vision impairment and blindness are on the rise.
      • The American Academy of Ophthalmology projects that by 2050, 7.32 million Americans will have primary open-angle glaucoma.
    • Demographic Impact:
      • Highest incidence among populations aged 70 to 79 years, women, and Hispanics.

    Key Players in the Market

    • Major Companies:
      • Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan Inc., Bayer AG, Novartis AG, GlaxoSmithKline PLC, Regeneron Pharmaceuticals Inc., among others.

    Advancements in Therapies

    • Gene Therapy Innovations:
      • Genentech’s Susvimo, approved by the FDA in 2021, offers a new treatment for wet age-related macular degeneration (AMD).
      • Susvimo requires fewer treatments per year compared to traditional therapies.

    Notable Acquisitions

    • Novartis Acquires Arctos Medical:
      • In September 2021, Novartis acquired Arctos Medical to enhance its vision loss solutions.
      • This acquisition leverages optogenetics for developing effective therapeutics.

    Market Segmentation

    • By Stage of Disease:
      • Early-Stage AMD, Intermediate AMD, Late-Stage AMD
    • By End User:
      • Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
    • By Route of Administration:
      • Oral, Injectable, Other Routes
    • By Types:
      • Wet Macular Degeneration, Dry Macular Degeneration

    Regional Insights

    • North America:
      • Largest region in the market in 2023.
    • Asia-Pacific:
      • Expected to be the fastest-growing region during the forecast period.

    The macular degeneration treatment market is on a robust growth trajectory, driven by technological advancements, increasing healthcare expenditure, and a growing elderly population. With continued innovation and investment, the future looks promising for advancements in managing and treating macular degeneration.

    Request A Sample Of The Global Macular Degeneration Treatment Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=5799&type=smp